
  
  
  
    
English
Generated Narrative: MedicationStatement mii-exa-medikation-medication-statement-caelyx
  
Profile: MII PR Medikation MedicationStatement version: 2027.0.0-ballot
Security Label: test health data (Details: ActReason code HTEST = 'test health data')
status: Active
medication: Medication Caelyx pegylated liposomal 2 mg/ml Konzentrat zur Herstellung einer Infusionslösung 1x25ml DSF N1
subject: Max Mustermann  Male, DoB: 1965-03-14 ( https://www.medizininformatik-initiative.de/fhir/core/modul-medikation/sid/patient#12345)
effective: 2020-01-02 09:30:00+0100
dosage
timing: Once per 4 weeks
route: Intravenous use
DoseAndRates
- Dose[x]
* 50 mg/m2 (Details: UCUM  codemg/m2 = 'mg/m2')